Y Intercept Hong Kong Ltd lessened its stake in Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 47.1% in the fourth ...
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
"Quite simply and astonishingly, this is dismantling the National Park Service as we know it, ranger by ranger and brick by ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Akero Therapeutics (AKRO – Research Report), ...
We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
4d
TipRanks on MSNAkero Therapeutics Reports Promising Clinical Trial ResultsAkero Therapeutics ( ($AKRO) ) has released its Q4 earnings. Here is a breakdown of the information Akero Therapeutics presented to its investors.
We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other ...
Grabar Law Office is investigating claims on behalf of Extreme Networks, Inc. (NASDAQ: EXTR) shareholders. The investigation concerns whether certain officers of Extreme Networks have breached their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results